Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in patients with rheumatoid arthritis who discontinued JAK inhibitor therapy

被引：0
|
作者：
Andrea, Amstad [1 ,2 ]
Eleftherios, Papagiannoulis [3 ]
Almut, Scherer [3 ]
Andrea, Rubbert-Roth [4 ]
Axel, Finckh [5 ]
Ruediger, Mueller [6 ]
Jean, Dudler [7 ]
Burkhard, Moller [8 ]
Peter, Villiger M. [9 ]
Martin, Schulz M. P. [10 ]
Diego, Kyburz [1 ,2 ]
机构：
[1] Univ Hosp Basel, Dept Rheumatol, Basel, Switzerland
[2] Univ Basel, Basel, Switzerland
[3] Swiss Clin Qual Management Fdn, Zurich, Switzerland
[4] Kantonsspital St Gallen, Clin Rheumatol, Kantonsspital St Gallen, St Gallen, Switzerland
[5] Univ Hosp Geneva, Div Rheumatol, Geneva, Switzerland
[6] Univ Basel, Kantonsspital Aarau, Univ Dept Med, Div Rheumatol,Med Fac, Aarau, Switzerland
[7] Hop Cantonal Fribourg, HFR Fribourg, Serv Rhumatol, Fribourg, Switzerland
[8] Univ Hosp Inselspital Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[9] Med Ctr Monbijou, Bern, Switzerland
[10] AbbVie AG, Cham, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2022年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 1
引用
收藏
页码：5S / 5S
页数：1
相关论文
共 50 条
  • [1] Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy
    Amstad, Andrea
    Papagiannoulis, Eleftherios
    Scherer, Almut
    Rubbert-Roth, Andrea
    Finckh, Axel
    Mueller, Ruediger
    Dudler, Jean
    Moeller, Burkhard
    Villiger, Peter M.
    Schulz, Martin M. P.
    Kyburz, Diego
    [J]. RHEUMATOLOGY, 2022, 62 (01) : 89 - 97
  • [2] DRUG RETENTION AND REASONS FOR DISCONTINUATION OF BIOLOGICS AND JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS - THE ANSWER COHORT STUDY
    Ebina, K.
    Etani, Y.
    Maeda, Y.
    Okita, Y.
    Hirao, M.
    Yamamoto, W.
    Hashimoto, M.
    Murata, K.
    Hara, R.
    Nagai, K.
    Hiramatsu, Y.
    Son, Y.
    Amuro, H.
    Fujii, T.
    Okano, T.
    Ueda, Y.
    Katayama, M.
    Okano, T.
    Kumanogoh, A.
    Okada, S.
    Nakata, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 234 - 235
  • [3] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Eun Ha Kang
    Katherine P. Liao
    Seoyoung C. Kim
    [J]. Current Rheumatology Reports, 2018, 20
  • [4] Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis
    Kang, Eun Ha
    Liao, Katherine P.
    Kim, Seoyoung C.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (07)
  • [5] DRUG RETENTION OF BIOLOGICS OR JAK INHIBITORS IN PATIENTS WITH DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS: RESULTS FROM THE ANSWER COHORT
    Watanabe, R.
    Okano, T.
    Yamada, S.
    Yamamoto, W.
    Murata, K.
    Murakami, K.
    Ebina, K.
    Maeda, Y.
    Jinno, S.
    Shirasugi, I.
    Son, Y.
    Amuro, H.
    Katayama, M.
    Hara, R.
    Hata, K.
    Yoshikawa, A.
    Hashimoto, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 527 - 528
  • [6] SAFETY OF THE JAK INHIBITORS IN COMPARISON WITH THE TNF INHIBITORS IN RHEUMATOID ARTHRITIS: REAL WORLD DATA FROM THE HONG KONG BIOLOGICS REGISTRY
    Mok, C. C.
    So, H.
    Ho, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1331 - 1332
  • [7] Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
    Choi, Se Rim
    Shin, Anna
    Ha, You-Jung
    Lee, Yun Jong
    Lee, Eun Bong
    Kang, Eun Ha
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 589 - 590
  • [8] RISK OF INFECTIONS BETWEEN JAK INHIBITORS AND TNF INHIBITORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
    Choi, S. R.
    Shin, A.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 716 - 716
  • [9] Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study
    Ebina, Kosuke
    Hirano, Toru
    Maeda, Yuichi
    Yamamoto, Wataru
    Hashimoto, Motomu
    Murata, Koichi
    Takeuchi, Tohru
    Nagai, Koji
    Son, Yonsu
    Amuro, Hideki
    Onishi, Akira
    Jinno, Sadao
    Hara, Ryota
    Katayama, Masaki
    Yamamoto, Keiichi
    Kumanogoh, Atsushi
    Hirao, Makoto
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (09) : 2563 - 2572
  • [10] Safety of JAK inhibitor use in patients with rheumatoid arthritis who developed herpes zoster after receiving JAK inhibitors
    Wonho Choi
    Soo Min Ahn
    Yong-Gil Kim
    Chang-Keun Lee
    Bin Yoo
    Seokchan Hong
    [J]. Clinical Rheumatology, 2022, 41 : 1659 - 1663
12345